Chikungunya vaccine
Chikungunya is spread by mosquitoes and often causes long-lasting joint pain. If you are travelling to an area with an active outbreak, a single dose can give you protection.
What is chikungunya?
Chikungunya is a viral disease spread by Aedes mosquitoes and found in parts of Asia, Africa, the Americas and a few areas of southern Europe. Over 90% of those infected develop symptoms, typically fever and severe joint pain.
Around 30-40% experience long-lasting joint problems that can resemble chronic arthritis, and for some the problems last for several years. Mortality is generally low, but older people and people with chronic diseases have a higher risk of a severe course. There is no specific treatment.
Who should be vaccinated?
We recommend the vaccine for travellers over 12 who are going to areas with a current outbreak and a high risk of infection. It can also be considered when travelling to areas where the virus has circulated within the last 5 years, especially for stays of more than 6 months.
Doses and vaccination schedule
The vaccine is given as a single dose and is approved from the age of 12. Clinical studies show a strong antibody response after just one dose, including in people over 65.
It is not yet known whether a booster dose will be needed later – preliminary studies point to protection for several years.
Side effects
- As with other injections, there may be local soreness, redness or swelling at the injection site as well as temporary discomfort
Most side effects are mild and go away on their own within 1-2 days. Serious side effects are rare. If you are unsure about anything after your vaccination, you are always welcome to contact us.
Who should not be vaccinated?
The vaccine is not recommended for people with a weakened immune system. If you have previously had a serious allergic reaction to any of the ingredients, you should not be vaccinated without a prior medical assessment.
Frequently asked questions
A single dose. It has not yet been determined whether revaccination will be needed later.
People with a weakened immune system or a previous serious allergic reaction to the ingredients.
Preliminary studies suggest protection for several years, but long-term data are still being collected.
The vaccine is approved from the age of 12.
Ready to get vaccinated?
See the full price list or book a time, and we will come to you in Copenhagen.